
    
      The purpose of this study is to determine the safety and efficacy of Cesamet™ in the
      symptomatic treatment of pain due to Multiple Sclerosis.

      This is a phase IV, multi-center, open label outpatient clinical trial evaluating Cesamet™
      treatment for control of pain due MS. The study has two phases: a Pretreatment Phase and a
      Treatment Phase.
    
  